SEC Form 4 · accession 0001209191-17-003947
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Standridge
Officer — Chief Operating Officer
Period of report
Jan 13, 2017
Accepted (ET)
Jan 17, 2017 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2017 | A | 13,600 | $0.00 | A | 80,267 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.02 | Jan 13, 2017 | A | 20,000 | A | — | Jan 12, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2018 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2021, subject to continued service with the Issuer through the applicable vesting dates.